Drug Trial Radar · NCT04041791
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
Last checked: Nov 19, 2026Latest source record: Jul 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,392
Actual
Start
Aug 19, 2019
Primary completion
Apr 5, 2024
Study completion Apr 5, 2024
Sponsor
- Lead sponsor
- University of OxfordAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Nairobi; London School of Hygiene and Tropical Medicine; National Institute for Health Research, United Kingdom; Department for International Development, United Kingdom; Medical Research Council; Wellcome Trust; Kenya Ministry of Health
- First posted
- Aug 1, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 months, up to 59 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pneumonia is one of the top causes of death in children aged below 5. More than 10% of children with severe pneumonia die. We are not sure that the currently recommended antibiotics used in children with pneumonia are the most effective. No studies have been carried out to find out whether children with pneumonia should be given intravenous (IV) fluids or nasogastric (NG) feeds. The SEARCH trial aims to find out which antibiotics and modes of feeding are the most effective in treating children with severe pneumonia and therefore helping reduce mortality.
Conditions
- Pneumonia
Interventions
Benzyl penicillinDrug
Benzyl penicillin is a penicillin antibiotic.
Gentamicin SulfateDrug
Gentamicin is an aminoglycoside antibiotic.
CeftriaxoneDrug
Ceftriaxone is a third generation cephalosporin antibiotic active against a wide range of gram negative and positive bacteria.
Amoxicillin ClavulanateDrug
Amoxicillin Clavulanate is a combination of amoxicillin, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor.
Intravenous fluidOther
Maintenance fluids administered for at least 24 hours.
Nasogastric feedsOther
Feeds given via nasogastric tube. Feeds may include cow's milk, breast milk, porridge, formula among others.
AmpicillinDrug
Ampicillin is a penicillin-type antibiotic.
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: Up to Day 5
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Machakos Level 5 Hospital
Machakos, Kenya
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.